Target intelligence / Profile preview

Dengue virus-1 antigens (DEN-1 E protein)

Target
DEN-1 E protein
Molecular classification
Viral protein, Envelope glycoprotein, Non-structural protein, Capsid protein
01

Overview

Dengue virus-1 antigens refers collectively to the proteins expressed by the Dengue virus serotype 1 (DENV-1) that are recognized by the immune system. Key antigens include the envelope (E) protein, which mediates viral entry and serves as the primary target for neutralizing antibodies; the capsid (C) protein, essential for genome encapsidation; the non-structural proteins (particularly NS1, NS3, and NS5), which are involved in viral replication and immune modulation; and the membrane (M/prM) protein, which is important for virion maturation. The E and NS1 proteins are utilized in diagnostics and are major therapeutic or vaccine targets. However, "Dengue virus-1 antigens" is a broad term and not a specific molecular target; for structured pharmacological purposes, referencing a specific DENV-1 protein is necessary[1][3][4][6].

Other names
DEN-1 antigensDENV1 antigensDENV1 proteinsdengue viral proteinsDENV type 1 envelope proteinDENV NS1DEN-1 EDEN-1 NS1
02

Mechanism of action

Inhibition of viral entry (E protein inhibitors and neutralizing antibodies); Inhibition of viral assembly/capsid formation (capsid inhibitors); Blockage of NS1-mediated immune modulation and vascular leakage (NS1 inhibitors/antibodies)

03

Biological functions

Viral entry (envelope/E protein)Immune evasion (NS proteins)Genome encapsidation (capsid protein)Viral replication (NS proteins)Virion assembly/maturation
04

Disease associations

Infection (Dengue fever, Dengue hemorrhagic fever, Dengue shock syndrome)
05

Safety considerations

Antibody-dependent enhancement (ADE): Non-neutralizing or cross-reactive antibodies to dengue antigens (especially E protein) can worsen disease in subsequent infectionsTarget variability: Antigenic differences between serotypes or within dengue virus type 1 can affect efficacy of therapeutics and diagnostics
06

Interacting drugs

Small molecule capsid inhibitor ST-148

7 more in the full profile.

07

Biomarkers

NS1 antigen detection (used for early diagnosis of dengue infection)

Beyond the preview

Go deeper on Dengue virus-1 antigens (DEN-1 E protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dengue virus-1 antigens (DEN-1 E protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call